Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | OXER1 | Q8TDS5 | 1/20 | 0.31 |
| ▸ | POLA1 | P09884 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2167274 | 1.00 | LMNA (0.41) | LMNAOXER1POLA1 | |
| SCHEMBL2167105 | 1.00 | LMNA (0.41) | LMNAOXER1POLA1 | |
| SCHEMBL2167271 | 1.00 | LMNA (0.41) | LMNAOXER1POLA1 | |
| SCHEMBL2167108 | 1.00 | LMNA (0.41) | LMNAOXER1POLA1 | |
| SCHEMBL6438604 | 0.88 | LMNA (0.45) | LMNAPOLA1 | |
| SCHEMBL6438607 | 0.88 | LMNA (0.45) | LMNAPOLA1 | |
| SCHEMBL3677583 | 0.85 | LMNA (0.59) | LMNA | |
| SCHEMBL3677585 | 0.85 | LMNA (0.59) | LMNA | |
| SCHEMBL3682711 | 0.81 | LMNA (0.34) | LMNA | |
| SCHEMBL3682709 | 0.81 | LMNA (0.34) | LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1970368-B1 | METHOD FOR PRODUCING OLEFIN COMPOUND | SUMITOMO CHEMICAL CO (JP) | 2012-08-29 | — | — | EP | disclosed |
| US-7985872-B2 | Method for producing olefin compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-07-26 | — | — | US | disclosed |
| US-7700799-B2 | Method for producing (2-formyl-1-alkenyl) cyclopropane compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-04-20 | — | — | US | disclosed |
| US-20090137839-A1 | METHOD FOR PRODUCING (2-FORMYL-1-ALKENYL) CYCLOPROPANE COMPOUND | SUMITOMO CHEMICAL COMPANY, LTD. (JP) | 2009-05-28 | — | — | US | disclosed |
| US-7498459-B2 | Method for producing (1-alkenyl)cyclopropane compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-03-03 | — | — | US | disclosed |
| US-20090036620-A1 | METHOD FOR PRODUCING OLEFIN COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-02-05 | — | — | US | disclosed |
| EP-1970368-A1 | METHOD FOR PRODUCING OLEFIN COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2008-09-17 | — | — | EP | disclosed |
| US-20070197818-A1 | Method for producing (1-alkenyl) cyclopropane compound | SUMITOMO CHEMICAL COMPANY, LIMITED | 2007-08-23 | — | — | US | disclosed |
| EP-1728781-A1 | PROCESS FOR PRODUCTION OF (1-ALKENYL)CYCLOPROPANES | Sumitomo Chemical Company, Limited (JP) | 2006-12-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090137839-A1 | METHOD FOR PRODUCING (2-FORMYL-1-ALKENYL) CYCLOPROPANE COMPOUND | ACSL3, ACSL1, ARL1 | LMNA 2696/4885OXER1 272/4885POLA1 2496/4885 |
| US-20070197818-A1 | Method for producing (1-alkenyl) cyclopropane compound | ACSL3, ARL1, ACSL1 | LMNA 3763/4885OXER1 675/4885POLA1 2638/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.